Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2

This study provides an overview of scientific results on the feasibility of using type III interferons against SARS-CoV-2. We have analyzed data obtained from the PubMed electronic database for the period 2020‒2022. The results of our own studies of pharmacological substances based on recombinant IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleinik, L. A., Madonov, P. G., Pykhtina, M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pleiades Publishing 2023
Materias:
Cell Molecular Biology: From DNA Repair to Metabolomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131541/
https://www.ncbi.nlm.nih.gov/pubmed/37128210
http://dx.doi.org/10.1134/S0026893323020152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131541/
https://www.ncbi.nlm.nih.gov/pubmed/37128210
http://dx.doi.org/10.1134/S0026893323020152

Ejemplares similares